Reuters Pharma

R&D

Eloise McLennan interview with Peter Stenico

Reuters Pharma Europe 2024 – Peter Stenico

Pioneering access to biosimilars is crucial for strengthening health equity by providing affordable, life-changing therapies to patients worldwide.

Digital

Reuters Pharma Europe 2024 – Day Three

As Reuters Pharma Europe 2024 comes to a close in Barcelona, pharmaphorum remains on site to live blog the last remaining talks and insights.

Digital

Reuters Pharma Europe 2024 – Day Two

And we’re live on site all day again on Day Two of Reuters Pharma Europe 2024 in Barcelona.

Digital

Jonah Comstock interview with Mindy McGrath at Reuters Pharma USA 24

Reuters Pharma USA 2024 – Mindy McGrath

One of the most salient topics in the United States right now in pharma is market access and drug affordability, and one thing that’s driving that topic in this moment are the drug pricing

Market Access

Reuters Pharma USA 2024 - Day 2

Wednesday brings much more Cell and Gene Therapy content, but we’ll also dip into the Marketing and Commercial tracks, looking at real-world evidence, value-based care, and omnichannel mark

Market Access